WORCESTER, Mass., Oct. 2, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that the United States Patent and Trademark Office has granted the Company a new United States Patent.
